DaVita
DVA
#2071
Rank
C$13.51 B
Marketcap
C$202.16
Share price
-0.15%
Change (1 day)
9.46%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): C$14.03

According to DaVita's latest financial reports the company's current EPS (TTM) is C$13.83. In 2024 the company made an earnings per share (EPS) of C$15.08 an increase over its 2023 EPS that were of C$10.40.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$14.03-6.96%
2024C$15.0844.94%
2023C$10.4027.26%
2022C$8.17-35.56%
2021C$12.6844.1%
2020C$8.8019.7%
2019C$7.35540.48%
2018C$1.15-76.07%
2017C$4.80-19.31%
2016C$5.95242.52%
2015C$1.74-62.87%
2014C$4.6713.43%
2013C$4.128.45%
2012C$3.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
C$32.08 131.92%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$14.39 4.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
C$20.09 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.60-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA